Use of Intranasal Midazolam to Reduce Stress and Procedural Pain in Premature Infants During Routine ROP Examination.

NCT06889376 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Drug Safety

Interventions

DRUG: Intranasal midazolam administration via the DART™ intranasal atomization device along with routine comfort care.

Sponsor

Polish Mother Memorial Hospital Research Institute